Literatur
-
1
Wreghitt T.
Chlamydial infections of the respiratory tract.
CDR Review.
1993;
9
119-124
-
2
Grayston J T.
Chlamydia pneumoniae, Strain TWAR.
Chest.
1989;
95
664-669
-
3
Gaydos C A, Summersgill J T, Sahney N N, Ramirez J A, Quinn T C.
Replication of Chlamydia pneumoniae in vitro in Human Macrophages, Endothelial Cells and Aortic Artery Smooth Muscle Cells.
Infect Immun.
1996;
64
1614-1620
-
4
Sriram S, Mitchell W, Stratton C.
Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS.
Neurology.
1998;
50
571-573
-
5 Robert-Koch-Institut .Epidemiologisches Bulletin Nr. 7 (18. Februar 2000): . 60
-
6
Grayston J T, Campbell L A, Kuo C C, Mordhorst C H, Saikku P, Thom D H, Wang S P.
A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWAR.
J Infect Dis.
1990;
161
618-625
-
7
Kleemola M, Saikku P, Visakorpi R, Wang S P, Grayston J T.
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.
J Infect Dis.
1988;
157
230-236
-
8
Hyman C, Augenbraun M H, Roblin P M, Schachter J, Hammerschlag M R.
Asymptomatic Respiratory Tract Infection with Chlamydia pneumoniae TWAR.
J Clin Microbiol.
1991;
29
2082-2083
-
9
Almirall J, Morato I, Riera F, Priu R.
Incidence of commmunity-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study.
Eur Respir J.
1993;
6
14-19
-
10
Fang G D, Fine M, Orloff J, Arisumi D, Yu V L, Kapoor W, Grayston J T, Wang S P, Kohler R, Muder R R, Yee Y C, Rihs J D, Vickers R M.
New and Emerging Etiologies für Community-Acquired Pneumonia with Implications for Therapy.
Medicine.
1990;
69
307-315
-
11
Marston B J, Plouffe J F, File Jr T M.
Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based surveillance study in Ohio.
Arch Intern Med.
1997;
157
1709-1718
-
12
Steinhoff D, Lode H, Ruckdeschel G, Heidrich B, Rolfs A, Fehrenbach F J, Mauch H, Höffken G, Wagner J.
Chlamydia pneumoniae as a cause of community acquired pneumonia in hospitalized patients in Berlin.
Clin Infect Dis.
1996;
22
958-964
-
13
Woodhead M.
Community-Acquired Pneumonia Guidelines - An International Comparison.
Chest.
1998;
113
183S-187S
-
14
Kauppinen M T, Lähde S, Syrjälä H.
Roentgenographic Findings of Pneumonia Caused by Chlamydia pneumoniae.
Arch intern Med.
1996;
156
1851-1856
-
15
Troy C J, Peeling R W, Ellis A G, Hockin J C, Bennett D A, Murphy M R, Spika J S.
Chlamydia pneumoniae as a New Source of Infectious Outbreaks in Nursing Homes.
JAMA.
1997;
277
1214-1218
-
16
Hammerschlag M R, Chirgwin K, Roblin P M, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J.
Persistent Infection with Chlamydia pneumoniae following Acute Respiratory Illness.
Clin Infect Dis.
1992;
14
178-182
-
17
Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, Sieper J.
Chlamydia pneumoniae, a new causative agent of reactive arthritis and undifferentiated oligoarthritis.
Ann Rheumatol Dis.
1994;
531
100-105
-
18
Marie I, Lecomte F, Levesque H, Janvresse C, Kerleau J M, Cailleux N, Courtois H.
Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: A prospective study.
Clin Infect Dis.
1999;
28
691-692
-
19
Heinemann M, Susa M, Simnacher U, Marre R, Essig A.
Growth of Chlamydia pneumoniae Induces Cytokine Production and Expression of CD 14 in a Human Monocytic Cell Line.
Infect Immun.
1996;
64
4872-4875
-
20
Krull M, Klucken A C, Wuppermann F N, Fuhrmann O, Magerl C, Seybold J, Hippenstiel S, Hegemann J H, Jantos C A, Suttorp N.
Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae.
J Immunol.
1999;
162
4834-4841
-
21
Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M.
Interaction of Chlamydia pneumoniae and Human Alveolar Macrophages: Infection and Inflammatory Response.
Am J Respir Cell Mol Biol.
1998;
19
721-727
-
22
Malinverni R, Kuo C C, Campbell L A, Grayston J T.
Reactivation of Chlamydia pneumoniae Lung Infection in Mice by Cortisone.
J Infect Dis.
1995;
172
593-594
-
23
Augenbraun M H, Roblin P M, Chirgwin K, Landman D, Hammerschlag M.
Isolation of Chlamydia pneumoniae from the Lungs of Patients Infected with the Human Immunodeficiency Virus.
J Clin Microbiol.
1991;
29
401-402
-
24
Blasi F, Cosentini R, Schöller M C, Lupo A, Allegra L.
Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan.
Thorax.
1993;
48
1261-1263
-
25
Dalhoff K, Maass M.
Chlamydia pneumoniae Pneumonia in Hospitalized Patients.
Chest.
1996;
110
351-356
-
26
Roblin P M, Hammerschlag M R.
Microbiologic efficacy of azithromycin and susceptibility to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.
Antimicrob Agents Chemother.
1998;
42
194-196
-
27
American Thoracic Society .
Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antmicrobial Therapy.
Am Rev Respir Dis.
1993;
148
1418-1426
-
28
Bartlett J G, Breiman R F, Mandell L A, File Jr T M.
Community-Acquired Pneumonia in Adults: Guidelines for Management.
Clin Infect Dis.
1998;
26
811-838
-
29
Hahn D L, Dodge R W, Golubjatnikov R.
Association of Chlamydia pneumoniae (Strain TWAR) Infection with Wheezing, Asthmatic Bronchitis and Adult-Onset Asthma.
JAMA.
1991;
266
225-230
-
30
Shemer-Avni Y, Lieberman D.
Chlamydia pneumoniae-Induced Ciliostasis in Ciliated Bronchial Epithelial Cells.
J Infect Dis.
1995;
171
1274-1278
-
31
Emre U, Sololovskaya N, Roblin P M, Schachter J, Hammerschlag M R.
Detection of Anti-Chlamydia pneumoniae IgE in Children with Reactive Airway Disease.
J Infect Dis.
1995;
172
265-267
-
32
Cook P J, Davies P, Tunnicliffe W, Ayres J G, Honeybourne D, Wise R.
Chlamydia pneumoniae and asthma.
Thorax.
1998;
53
254-259
-
33
Cunningham A F, Johnston S L, Julious S A, Lampe F C, Ward M E.
Chronic Chlamydia pneumoniae infection and asthma exacerbations in children.
Eur Respir J.
1998;
11
345-349
-
34
Hahn D L, Mc Donald R.
Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma.
Ann Allergy Asthma Immunol.
1998;
81
339-344
-
35
von Hertzen L, Toyryla M, Gimishanow A, Bloigu A, Leinonen M, Saikku P, Haahtela T.
Asthma, atopy and Chlamydia pneumoniae antibodies in adults.
Clin Exp Allergy.
1999;
29
522-528
-
36
Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, Gouarin S, Duhamel J F, Guillois B.
Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children.
J Clin Virol.
1999;
13
131-139
-
37
Miyashita N, Kubota Y, Nakajima M, Niki Y, Kawane H, Matsushima T.
Chlamydia pneumoniae and exacerbations of asthma in adults.
Ann Allergy Asthma Immunol.
1998;
80
405-409
-
38
Black P, Jenkins C, Blasi F, Allegra L, Scichitano R, Mills G, Rubinfeld A, Ruffin R.
Chlamydia pneumoniae asthma roxithromycin multinational study (CARM).
Eur Respir J.
1999;
14, S30
289s
-
39
Beaty C D, Grayston J T, Wang S P, Kuo C C, Reto C S, Martin T R.
Chlamydia pneumoniae, Strain TWAR, Infection in Patients with Chronic Obstructive Pulmonary Disease.
Am Rev Respir Dis.
1991;
148
1408-1410
-
40
Miyashita N, Niki Y, Nakajima M, Kawane H, Matsushima T.
Chlamydia pneumoniae Infection in Patients with Diffuse Panbronchiolitis and COPD.
Chest.
1998;
114
969-971
-
41
Mogulkoc N, Karakurt S, Isalska B, Bayindir Ü, Celikel T, Korten V, Colpan N.
Acute Purulent Exacerbation of Chronic Obstructive Pulmonary Disease and Chlamydia pneunomiae infection.
Am J Respir Crit Care Med.
1999;
160
349-353
-
42 Theegarten D, Mogilevski G, Anhenn O, Stamatis G, Jaeschok R, Morgenroth K. The role of chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis. Virchows Arch 437: in press 2000
-
43
Meier C R, Jick S S, Derby L E, Vasilakis C, Jick H.
Acute respiratory-tract infection and risk of first-time acute myocardial infarction.
Lancet.
1998;
351
1467-1471
-
44
Saikku P, Mattila K, Nieminen M S, Hutten J K, Leionen M, Ekman M R, Makela P H, Valtona V.
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic heart disease and acute myocardial infarction.
Lancet.
1988;
ii
983-985
-
45
Danesh J, Collins R, Peto R.
Chronic infections and coronary heart disease: is there a link.
Lancet.
1997;
350
430-436
-
46
Maass M, Gieffers J.
Prominent serological response to Chlamydia pneumoniae in cardiovascular disease.
Immunol Infect Dis.
1996;
6
65-70
-
47
Maass M, Bartels C, Engel P M, Mamat U, Sievers H H.
Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease.
J Am Coll Cardiol.
1998;
31
827-832
-
48
Campbell L A, O'Brien E R, Cappuccio A L, Kuo C C, Wang S P, Stewart D, Patton D L, Cummings P K, Grayston J T.
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.
J Infect Dis.
1995;
172
585-588
-
49
Ramirez J A.
Isolation of Chlamydia pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis.
Ann Intern Med.
1996;
125
979-982
-
50
Moazed T C, Kuo C C, Grayston J T, Campbell L A.
Evidence of Systemic Dissemination of Chlamydia pneumoniae via Macrophages in the Mouse.
J Infect Dis.
1998;
177
1322-1325
-
51
Maass M, Jahn J, Gieffers J, Dalhoff K, Katus H A, Solbach W.
Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction.
J Infect Dis.
2000;
181 S3
S449-S451
-
52
Lin T M, Campbell L A, Rosenfeld E M, Kuo C C.
Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae.
J Infect Dis.
2000;
181
1096-1100
-
53
Kothe H, Dalhoff K, Rupp J, Müller A, Kreuzer J, Maass M, Katus H A.
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Modify the Inflammatory Response of Human Macrophages and Endothelial Cells Infected with Chlamydia pneumoniae.
Circulation.
2000;
101
1760-1763
-
54
Laitinen K, Lauvila A, Pyhala L, Leinonen M, Saikku P.
Chlamydia pneumoniae infection induces inflammatory changes in the aorta of rabbits.
Infect Immun.
1997;
65
4832-4835
-
55
Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B.
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: Roxis pilot study.
Lancet.
1997;
350
404-407
-
56
Gupta S, Leatham E W, Carrington D, Mendall M A, Kaski J C, Camm A J.
Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction.
Circulation.
1997;
96
404-407
-
57
Anderson J L, Muhlestein J B, Carlquist J, Allen A, Trehan S, Nielson C, Hall S, Brady J, Egger M, Horne B, Tim T.
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
Circulation.
1999;
99
1540-1547
-
58
Nakamura H, Fujishima S, Inoue T, Ohkubo Y, Soejima K, Waki Y, Mori M, Urano T, Sakamaki F, Tasaka S, Ishizaka A, Kanazawa M, Yamaguchi K.
Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection.
Eur Respir J.
1999;
13
1371-1379
-
59
Shimizu T, Kato M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T.
Roxithromycin Reduces the Degree of Bronchial Hyperresponsiveness in Children with Asthma.
Chest.
1994;
106
458-461
-
60
Kaesemeyer W H, Caldwell R V, Huang J, Caldwell R W.
Pravastatin sodium activates endothelial nitric oxide synthase independent of ist cholesterol lowering action.
J Am Coll Cardiol.
1999;
31 (1)
234-241
-
61
Sacks F M, Pfeffer M A, Moye L A, Rouleau J L, Rutherford J D, Cole T G, Brown L, Warnica J W, Arnold J MO, Wun C C, Davis B R, Braunwald E.
The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
N Engl J Med.
1996;
14
1001-1009
-
62
Gieffers J, Solbach W, Maass M.
In vitro susceptibility of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries.
Antimicrob Agents Chemother.
1998;
42
2762-2764
Prof. Dr. med K Dalhoff
Medizinische Universität Lübeck Medizinische Klinik II
Ratzeburger Allee 160 23538 Lübeck
Email: E-mail: klaus.dalhoff@medinf.mu-luebeck.de
